Samsung Biologics Co Ltd
KRX:207940

Watchlist Manager
Samsung Biologics Co Ltd Logo
Samsung Biologics Co Ltd
KRX:207940
Watchlist
Price: 949 000 KRW 1.06% Market Closed
Market Cap: 67.5T KRW
Have any thoughts about
Samsung Biologics Co Ltd?
Write Note

Wall Street
Price Targets

Price Targets Summary
Samsung Biologics Co Ltd

Wall Street analysts forecast Samsung Biologics Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Samsung Biologics Co Ltd is 1 252 101 KRW with a low forecast of 848 400 KRW and a high forecast of 1 470 000 KRW.

Lowest
Price Target
848 400 KRW
11% Downside
Average
Price Target
1 252 101 KRW
32% Upside
Highest
Price Target
1 470 000 KRW
55% Upside
Samsung Biologics Co Ltd Competitors:
Price Targets
688114
MGI Tech Co Ltd
3% Upside
WST
West Pharmaceutical Services Inc
12% Upside
4880
CellSource Co Ltd
97% Upside
688046
GemPharmatech Co Ltd
39% Upside
LONN
Lonza Group AG
19% Upside
688238
Obio Technology Shanghai Corp Ltd
21% Upside
MEDP
Medpace Holdings Inc
7% Upside
ICLR
ICON PLC
39% Upside

Revenue
Forecast

Revenue Estimate
Samsung Biologics Co Ltd

For the last 8 years the compound annual growth rate for Samsung Biologics Co Ltd's revenue is 59%. The projected CAGR for the next 3 years is 17%.

59%
Past Growth
17%
Estimated Growth
Estimates Accuracy
4%
Average Beat

Operating Income
Forecast

Operating Income Estimate
Samsung Biologics Co Ltd

The compound annual growth rate of Samsung Biologics Co Ltd's operating income for the next 3 years is 21%.

N/A
Past Growth
21%
Estimated Growth
Estimates Accuracy
4%
Average Beat

Net Income
Forecast

Net Income Estimate
Samsung Biologics Co Ltd

For the last 8 years the compound annual growth rate for Samsung Biologics Co Ltd's net income is -10%. The projected CAGR for the next 3 years is 21%.

-10%
Past Growth
21%
Estimated Growth
Estimates Accuracy
3%
Average Beat

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Samsung Biologics Co Ltd's stock price target?
Price Target
1 252 101 KRW

According to Wall Street analysts, the average 1-year price target for Samsung Biologics Co Ltd is 1 252 101 KRW with a low forecast of 848 400 KRW and a high forecast of 1 470 000 KRW.

What is Samsung Biologics Co Ltd's Revenue forecast?
Projected CAGR
17%

For the last 8 years the compound annual growth rate for Samsung Biologics Co Ltd's revenue is 59%. The projected CAGR for the next 3 years is 17%.

What is Samsung Biologics Co Ltd's Operating Income forecast?
Projected CAGR
21%

The compound annual growth rate of Samsung Biologics Co Ltd's operating income for the next 3 years is 21%.

What is Samsung Biologics Co Ltd's Net Income forecast?
Projected CAGR
21%

For the last 8 years the compound annual growth rate for Samsung Biologics Co Ltd's net income is -10%. The projected CAGR for the next 3 years is 21%.

Back to Top